Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Obesity Treatment > Chinese Markets for Anti-Obesity Drugs
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Chinese Markets for Anti-Obesity Drugs

Published by Asia Market Information & Development
Published April, 2009 Product code 86346
Content info 180 Pages
Price
US $ 4000 PDF by E-mail (Single User License)
US $ 8000 PDF by E-mail (Corporate Use License)


Chinese Markets for Anti-Obesity Drugs published by Asia Market Information & Development in April, 2009. This report consists of 180 Pages and the price starts from US $ 4000.

Introduction

Abstract

China' s demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through 2013 and 2018 are presented. Major producers in China are profiled.

Table of Contents

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II.BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Structure
    • Market Size
    • Market Growth Drivers
    • Anti-Obesity Drugs Industry Capacity
    • Major Producer Facility Locations and Output
    • Locations
    • Output
    • Market Share of Key Producers
    • Labor Cost
    • Potential Entrants
    • Major Distributors
    • Major Foreign Investments
    • Technology Development

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Overview
    • Demand of Anti-Obesity Drugs by Region
    • Anti-Obesity Drugs Production and Demand
    • Sibutramine
    • Major Manufacturers
    • Supply and Demand
    • Traditional Chinese Medicine
    • Major Manufacturers
    • Supply and Demand
    • Orlistat
    • Major Manufacturers
    • Supply and Demand
    • Rimonabant
    • Major Manufacturers
    • Supply and Demand
    • Metformin
    • Major Manufacturers
    • Supply and Demand
    • Other Anti-Obesity Drugs
    • Anti-Obesity Drugs Imports and Exports
    • Anti-Obesity Drugs Imports
    • Anti-Obesity r Drugs Exports
    • Pricing Trend

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China' s Distribution System
  • Cough Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China' s Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

  • Profiles of Anti-Obesity Drugs Producers and Major Suppliers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Output
  • Major Producer Facility Location
  • Major Anti-Obesity Drugs Producer Output in 2007
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Anti-Obesity Drugs Production and Demand
  • Demand of Anti-Obesity Drugs by Region in 2004
  • Major Sibutramine Producer Output and Capacity in 2007
  • Sibutramine Drugs Production and Demand
  • Major Traditional Chinese medicine Producer Output and Capacity in 2007 Traditional Chinese Medicine Production and Demand
  • Major Orlistat Producer Output and Capacity in 2007
  • Olistat Production and Demand
  • Rimonabant Production and Demand
  • Major Metformin Producer Output and Capacity in 2007
  • Metformin Production and Demand
  • Other Anti-obesity Drugs Production and Demand
  • China Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Industry Output
  • Major Producer Facility Location
  • Major Anti-Obesity Drugs Producer Output in 2007
  • Market Share of Key Producers in 2007
  • Major Foreign Investment in China

LIST OF CHARTS

I. INTRODUCTION

  • China' s Anti-Obesity Drugs Capacity, Output, Demand

II. BUSINESS ENVIRONMENT

  • China' s GDP and Growth Rate
  • Industrial Output by Ownership
  • China' s Imports and Exports

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Capacity in China
  • All kinds of Anti-Obesity Drugs Market Share
  • Anti-Obesity Drugs Capacity, Output and Demand

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Total Anti-Obesity Drugs Production and Demand
  • Total Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Demand by Market in 2009

VI. MARKETING STRATEGIES

  • China' s Distribution Channel
Back to Top